Published • loading... • Updated
Fermenta Board Approves INR 110 Crore Capex at Dahej for Plant-based Vitamin D3, Green Chemistry Enzyme, and Vitamin D3 Derivatives
Summary by Latestly
1 Articles
1 Articles
Fermenta Board Approves INR 110 Crore Capex at Dahej for Plant-based Vitamin D3, Green Chemistry Enzyme, and Vitamin D3 Derivatives
Get latest articles and stories on Business at LatestLY. Thane (Maharashtra) [India], December 11: Fermenta Biotech Limited (BSE: 506414) (Bloomberg: FERMENTA.IN) (Reuters: FERM.BO), India's leading manufacturer of premium-grade nutritional ingredients, intermediates, nutritional premixes and green chemistry for the global markets, today announced that its Board of Directors has approved a capital investment of INR 110 crore for expanding capaci…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right1Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
